Effect on the behaviour of dexmedetomidine as anaesthetic premedication in the paediatric population: a prospective...

Area of Science:

• Anesthesiology
• Pediatric Medicine
• Pharmacology

Background:

• Premedication is crucial for pediatric anxiety reduction and anesthetic induction.
• Midazolam and ketamine, while effective, have potential long-term neurodevelopmental concerns.
• Dexmedetomidine offers sedation and analgesia without neurotoxicity, with intranasal administration being minimally invasive.

Observation:

• The study evaluated intranasal dexmedetomidine (2 mcg/kg) in 30 pediatric patients (ASA 1-2) for elective surgery.
• Sedation and behavioral effects were assessed at 10, 20, and 30 minutes post-administration.
• Acceptance for operating room admission was defined by sedation and behavior scores of 3 or 4.

Findings:

• At 30 minutes, 46.6% of patients achieved acceptable sedation scores.
• Behavioral scores were acceptable in 96% of cases.
• Facial mask acceptance for inhalation induction was achieved in 63% of patients, with 100% parental satisfaction.

Implications:

• Intranasal dexmedetomidine presents a safe and effective premedication option for pediatric surgical patients.
• The minimally invasive nature and positive outcomes support its use in reducing perioperative anxiety.
• Further research can explore optimal dosing and broader applications in pediatric anesthesia.